杨宁介入医学网

每年一度的热点问题辩论开始在 今天中午在北 Moscone 中心 斯坦福大学影像学教授 Daniel sze 主持了这一所谓 edu-tainment 会议。 Daniel sze 年轻的时候 人们在表达严肃的科学信息的时候，不见得非要严肃。也可是以幽默的形式。除了那些想学习某种特定技术...

Ziv Haskal Michael Dake Gary Siskin SIR多学科专家委员会发布评价CCSVI介入治疗研究讨论结果，并说目前还没有大样本的多中心研究。自SIR芝加哥会议以来，围绕未被证实的CCSVI综合征的许多关键问题一直被高度关注。 SIR会议同意现有的特殊参数上CCSVI尚没有...

一月在美国迈阿密 ISET( The International Symposium on Endovascular Therapy ) 会议上, 德国法兰克福心血管中心的Horst Sievert 告诉他的听众，为什么他认为肾去神经支配术和经皮冠状动脉介入或经皮血管成形术一样重要。我认为肾去神经支配术对于介入医生...

First US peripheral artery disease patient enrolled in CONNECT II trial Tuesday, 13 Mar 2012 09:43 Ocelot Avinger has announced the enrolment of the first US patient in the multicentre, non-randomised CONNECT II global clinical trial desig...

SIR 将在本次会议强调微创医学的进步和新的发现，可能改变现代医学许多种疾病的治疗方法。 预计超过5000名医生、科研人员和有关的卫生专业人员被期待参加这次重要介入放射学会议。这次会议的主题是介入放射学的证据，将反映SIR致力于该领域增长和发展，并证...

With more than 6,100 participants, the CIRSE annual meeting is the largest and most comprehensive forum for experts in image-guided minimally invasive therapies. The CIRSE Annual Congress and Postgraduate Course isa trend-setting, dynamic...

ECIO 2012 News Dont miss the deadline Our Early Bird registration deadline will only be available until February 16, 2012: Dont miss the chance to save to up 15% on the registration fee! REGISTER NOW! Accommodation The CIRSE Travel Service...

Colon Cancer Survival Improved With Use Of Oxaliplatin In 2011, about 101,340 Americans have been diagnosed with colon cancer, a leading worldwide cause of both illness and death, with around one third of cancers being diagnosed as stage I...

Colon Cancer Survival Improved With Use Of Oxaliplatin In 2011, about 101,340 Americans have been diagnosed with colon cancer, a leading worldwide cause of both illness and death, with around one third of cancers being diagnosed as stage I...

Colon Cancer Survival Improved With Use Of Oxaliplatin In 2011, about 101,340 Americans have been diagnosed with colon cancer, a leading worldwide cause of both illness and death, with around one third of cancers being diagnosed as stage I...